Business
Appointment of NED
Appointment of NED.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n \nRNS Number : 6428B Creo Medical Group PLC 03 February 2020 \n\n \n \nCreo Medical Group plc\n(\"Creo\" the \"Company\" or the \"Group\")\n \nAppointment of NED\n \nCreo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces the appointment of Ivonne Cantu as an independent Non-Executive Director to the Company with effect from 1 February 2020.\n \nIvonne has extensive experience in corporate finance acting as corporate finance adviser to UK and international companies for more than 20 years at Cenkos Securities plc and previously at Merrill Lynch. Ivonne is currently Director of Investor Relations and Corporate Development at Benchmark Holdings plc, the AIM listed aquaculture technology company. Ivonne holds a BSc in Engineering from Universidad Panamericana and an MBA from the Wharton School of Business.\n \nOn appointment, Ivonne will become Chair of the Company's Remuneration Committee.\n \nCharles Spicer, Non- Executive Chairman of Creo, said: \"We are pleased to welcome Ivonne to the Board. She has known Creo since we were a private company and brings a wealth of experience from her career in the City, which we are confident will make a major contribution to the success of Creo.\"\n \nIvonne Maria Gloria Cantu (aged 51), holds or has held the following directorships in the past five years:\n \n\n\n\n\nCurrent Directorships \n\n\nDirectorships held within the last five years\n\n\n\n\nLa Vida - Vital Investment for Development Aid in Latin America (trustee)\n\n\nCenkos Securities (Trustees) Limited\n\n\n\n\n \nIvonne Cantu does not hold any ordinary shares in the Company. There are no further details to be disclosed pursuant to Schedule Two Paragraph (g) of the AIM Rules for Companies.\n \nEnquiries:\n \n\n\n\n\nCreo Medical Group plc\n\n\ninvestors.creomedical.com\n\n\n\n\nRichard Rees (CFO)\n\n\n+44 (0)1291 606 005\n\n\n\n\n \n\n\n \n\n\n\n\nCenkos Securities\n\n...